Neurofibromatosis 2 with peripheral neuropathies: Electrophysiological, pathological and genetic studies of a Taiwanese family

Neuropathology

Volumn 30, Issue 5, 2010, Pages 515-523

  Kuo, Hung Chou ^a   Chen, Shyue Ru ^a   Jung, Shih Ming ^a   Wu Chou, Yah Huei ^a   Huang, Chin Chang ^a   Chuang, Wen Li ^a   Wei, Kuo Chen ^a   Ro, Long Sun ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

"two hit" hypothesis; electrophysiological study; neurofibromatosis type 2; peripheral neuropathy; sural nerve biopsy

Indexed keywords

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA SEQUENCE; ELECTROPHYSIOLOGY; FEMALE; FRAMESHIFT MUTATION; GENE; GENETIC ANALYSIS; GENETIC LINKAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NERVE BIOPSY; NERVE FIBER; NEUROFIBROMATOSIS; NF2 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCHOOL CHILD; SCHWANN CELL; SURAL NERVE; TAIWAN; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLICATION; GENETICS; MIDDLE AGED; NERVE CONDUCTION; NEUROFIBROMATOSIS TYPE 2; PATHOLOGY; PATHOPHYSIOLOGY; PEDIGREE; TUMOR SUPPRESSOR GENE; ULTRASTRUCTURE; YOUNG ADULT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FRAMESHIFT MUTATION; GENES, NEUROFIBROMATOSIS 2; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; NEUROFIBROMATOSIS 2; PEDIGREE; PERIPHERAL NERVOUS SYSTEM DISEASES; SCHWANN CELLS; SURAL NERVE; TAIWAN; YOUNG ADULT;

EID: 77957309696     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2009.01099.x     Document Type: Article

References (24)

1. Baser ME, Evans DGR, Gutmann DH. Neurofibromatosis 2. Curr Opin Neurol 2003 16 : 27 33.
2. Evans DGR, Huson SM, Donnai D et al. A genetic study of type 2 neurofibromatosis in the UK. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 1992 29 : 841 846.
3. McClatchey AI, Giovanni M. Membrane organization and tumorigenesis - the NF2 suppressor, MerlGenes Dev 2005 19 : 2265 2277.
4. Sperfeld AD, Hein C, Schroder JM, Ludolph AC, Hanemann CO. Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2. Brain 2002 125 : 996 1004.
5. Gijtenbeek JM, Gabreels-Festen AA, Lammens M et al. Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2. Neurology 2001 56 : 1766 1768.
6. Hagel C, Lindenau M, Lamszus K et al. Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens. Acta Neuropathol 2002 104 : 179 187.
7. MacCollin M. Clinical aspects. In : Friedman JM, Gutmann DH, MacCollin M, Ricardi VM, eds. Neurofibromatosis, 3rd edn. Baltimore, MD : John Hopkins University Press, 1999 299 326.
8. Eldridge R, Parry DM, Kaiser-Kupfer MI. Neurofibromatosis 2: clinical heterogeneity and natural history in 39 individuals in 9 families and 16 sporadic cases. Am J Hum Genet 1991 49 (Suppl. A133.
9. Ruttledge MH, Adermann AA, Phelan CM et al. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 1996 59 : 331 342.
10. Kimura J. Nerve conduction studies. In : Kimura J 3rd, ed. Electrodiagnosis of Disease of Nerve and Muscle: Principle and Practice, 3rd edn. New York : Oxford University Press, 2001 63 236.
11. Behse F, Buchthal F, Carlsen F, Knappeis GG. Unmyelinated Schwann cells of sural nerve in neuropathy. Brain 1975 98 : 493 510.
12. Jacobs JM, Love S. Qualitative and quantitative morphology of human sural nerve at different age. Brain 1985 108 : 897 924.
13. Kanda T, Tsukagoshi H, Oda M, Miyamoto K, Tanabe H. Morphological changes in unmyelinated nerve fibres in the sural nerve with age. Brain 1991 114 : 585 599.
14. Gutmann DH, Aylsworth A, Carey JC et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997 278 : 51 57.
15. Bourn D, Strachan T. Highly polymorphic dinucleotide repeat at the NF2 gene. Hum Genet 1995 95 : 712.
16. Marineau C, Baron C, Delattre O et al. Denucleotide repeat polymorphism at the D22S268 locus. Hum Mol Genet 1993 2 : 236.
17. Kuo HC, Chu CC, Jung SM et al. An unusual course of peripheral neuropathy in neurofibrosis type 2. J Clin Neuromusc Dis 2004 5 : 195 201.
18. Kilpatrick TJ, Hjorth RJ, Gonzale S. A case of neurofibromatosis 2 presenting with a mononeuritis multiplex. J Neurol Neurosurg Psychiatry 1992 55 : 391 393.
19. Trivedi R, Byrne J, Huson SM et al. Focal amyotrophy in neurofibromatosis 2. J Neurol Neurosurg Psychiatry 2000 69 : 257 261.
20. Iwata A, Kunimoto M, Inouse K. Schwann cell proliferation as the cause of peripheral neuropathy in neurofibromatosis 2. J Neurol Sci 1998 156 : 201 204.
21. Hanemann CO, Diebold R, Kaufmann D. Role of NF2 haploinsuffiency in NF2-associated polyneuropathy. Brain Pathol 2007 17 : 371 376.
22. Previtali SC, Nodari A, Taveggia C et al. Expression of laminin receptors in Schwann cell differentiation: evidence for distinct roles. J Neurosci 2003 23 : 5520 5530.
23. Scheter SS, Salzer JL. Axon-Schwann cell interactions during peripheral nerve degeneration and regeneration. In : Jessen KR, Richardson WD, eds. Glial cell Development, 2nd edn. Oxford : Oxford University Press, 2001 299 330.
24. Akassoglou K, Yu WM, Akpinar P et al. Fribrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation. Neuron 2002 33 : 861 875.